Europska Unija - islandski - EMA (European Medicines Agency)

roche registration gmbh  - pralsetinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Europska Unija - islandski - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

medac gesellschaft für klinische spezialpräparate gmbh - mitomycinum inn - duft og leysir fyrir þvagblöðrulausn - 40 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - tafla - 5 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - tafla - 2 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 10 mg/2,5 ml

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 50 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 25 mg

Island - islandski - LYFJASTOFNUN (Icelandic Medicines Agency)

dechra regulatory b.v. - phenobarbitalum inn - tafla - 100 mg